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Purpose: To present an unusual case of cytomegalovirus (CMV) retinitis in a patient with 
Wegener’s granulomatosis.
Results: A 54-year-old lady with Wegener’s granulomatosis presented with decreased vision 
in her left eye. Wegener’s retinal vasculitis was diagnosed initially and the patient received 
treatment with oral steroids. Three days later the patient developed typical CMV retinitis.
Conclusion:  The likelihood of CMV retinitis in patients with Wegener’s granulomatosis should 
not be overlooked. Increased awareness in such cases is very important since CMV retinitis may 
present with less typical manifestations, which makes the correct diagnosis more challenging.
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Introduction
Cytomegalovirus (CMV) is the main cause of infectious retinitis in severely 
immunosuppressed hosts (Pertel et al 1992). Wegener’s granulomatosis is an immune-
mediated disorder with frequent eye involvement. CMV retinitis is extremely uncom-
mon in these patients and it may present with atypical characteristics posing diagnostic 
dilemmas.
We present a case of CMV retinitis in a patient with Wegener’s granulomatosis 
which was diagnosed and treated initially as Wegener’s retinal vasculitis.
Case report
A 54-year-old female patient presented at the Ophthalmic clinic complaining of mild 
eye discomfort and gradual reduction of vision in her left eye over the previous 10 days. 
The patient had a history of meningitis in the past and surgery for removal of pituitary 
adenoma 13 years ago.  Four years earlier she developed central nervous system vasculitis 
and was diagnosed with Wegener’s granulomatosis. At presentation the patient was 
immunosuppressed due to her treatment with methylprednizolone 5 mgr/day and 
cyclophosphamide 1.5 mgr/kg/day.
On examination her best corrected visual acuity (BCVA) in the symptomatic left 
eye was 6/9–2. Blood tests and chest X-ray excluded other inﬂ  ammatory conditions, 
however, CD-4 levels was 180/mm3.  There was no activity from the anterior chamber, 
however, there was mild vitritis. B-mode ultrasound excluded scleritis with normal 
scleral thickness and fundoscopy revealed vasculitis and a few cotton wool spots 
in the peripapillary area and along the vascular arcades sparing the macula. At that 
time her clinical picture was consistent with Wegener’s retinal vasculitis and her oral 
prednisolone was increased to 60 mgr/day (1 mg/Kg). Further deterioration in her 
BCVA was noted when the patient was reviewed 3 days later. Fundus examination 
revealed moderate to severe vitritis ,retinitis and development of typical “pizza-pie” 
appearance of CMV retinitis was noted (Figure 1). The right eye was uninvolved. Clinical Ophthalmology 2008:2(4) 962
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Based on the clinical manifestations, the patient was initiated 
on intravenous gancyclovir 5 mg/kg twice a day.
Ten days later there was no further progression of retinitis 
and vitritis was minimal. Subsequently the ﬁ  rst signs of 
improvement were apparent, with regression of exudates, 
reduction of retinal hemorrhages and development of retinal 
pigment epithelial changes. Gancyclovir was reduced to 
5 mgr/kgr once a day and it was discontinued two months 
following complete regression of CMV retinitis (Figure 2).
Four months later, in the last follow-up examination, the 
patient’s vision remained stable at presentation levels.
Discussion
Ocular disease occurs in 29% to 58% of patients with 
Wegener’s granulomatosis. The three main categories of 
ocular involvement are scleritis with or without peripheral 
keratitis, orbital disease, and vasculitis-mediated vascular 
complications (Haynes et al 1977; Hoffman et al 1992).
With the advent of corticosteroid and especially cytotoxic 
drugs, which altered the outlook for the disease, the prognosis 
of Wegener’s granulomatosis has improved considerably. 
However, the use of immunomodulators may be associated 
with several systemic adverse effects and since the patients’ 
immune system is compromised there is a potentially 
increased risk of opportunistic infections.
Interestingly, CMV retinitis is extremely rare when 
associated with Wegener’s granulomatosis (Nicholson 1975; 
Riordan-Eva et al 1993; Tanihar et al 1993; Tugal-Tutkun et al 
2000; Bertelmann et al 2005). In the case described above the 
minimal signs of retinitis and the minimal amount of vitritis, 
on presentation lead to the diagnosis of  Wegener’s vasculitis. 
Wegener’s granulomatosis is always related to arteritis 
while CMV retinitis, which more frequently starts from the 
periphery, is related to vasculitis. Interestingly, in our case, 
infection was started from the posterior pole involving the 
optic disc and the peripappilary area.
This case points out that the possibility of CMV retinitis, 
although very rare, should not be overlooked in patients with 
Wegener’s granulomatosis. Increased awareness in these 
patients is very important especially if we consider that CMV 
Figure 1 Color photograph showing retinitis with scatter retinal hemorrhages in the peripapillary area and along the vascular arcades. Fundal details appear blurred due to 
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retinitis may present with less typical manifestations making 
the correct diagnosis more challenging. Prompt treatment 
with administration of antiviral agents is mandatory for 
the arrest of retinitis progression, earlier rehabilitation and 
prevention of more sinister complications.
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Figure 2 Regression of retinitis following treatment with ganciclovir, leaving retinal pigment epithelial changes and pale optic disc.